Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 5, 2008 - Issue 3
Submit an article Journal homepage
158
Views
28
CrossRef citations to date
0
Altmetric
Review

Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide

Drazen Raucher Associate Professor, University of Mississippi Medical Center, Department of Biochemistry, 2500 North State Street, Jackson, MS 39216, USA +1 601 984 1510; +1 601 984 1501; [email protected]
,
Iqbal Massodi Graduate Student, University of Mississippi Medical Center, Department of Biochemistry, 2500 North State Street, Jackson, MS 39216, USA [email protected]
&
Gene L Bidwell III Postdoctoral Fellow, University of Mississippi Medical Center, Department of Biochemistry, 2500 North State Street, Jackson, MS 39216, USA [email protected]
Pages 353-369 | Published online: 05 Mar 2008

Bibliography

  • Draeger LJ, Mullen GP. Interaction of the bHLH-zip domain of c-Myc with H1-type peptides. Characterization of helicity in the H1 peptides by NMR. J Biol Chem 1994;269(3):1785-93
  • Giorello L, Clerico L, Pescarolo MP, et al. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Cancer Res 1998;58(16):3654-9
  • Clark GJ, Drugan JK, Terrell RS, et al. Peptides containing a consensus Ras binding sequence from Raf-1 and the GTPase activating protein NF1 inhibit Ras function. Proc Natl Acad Sci USA 1996;93(4):1577-81
  • Rojas M, Yao S, Lin YZ. Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J Biol Chem 1996;271(44):27456-61
  • Khalil MW, Sasse F, Lunsdorf H, et al. Mechanism of action of tubulysin, an antimitotic peptide from myxobacteria. Chembiochem 2006;7(4):678-83
  • Ellerby HM, Arap W, Ellerby LM, et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 1999;5(9):1032-8
  • Friedman PN, McAndrew SJ, Gawlak SL, et al. BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells. Cancer Res 1993;53(2):334-9
  • Kashiwagi H, McDunn JE, Goedegebuure PS, et al. TAT-Bim induces extensive apoptosis in cancer cells. Ann Surg Oncol 2007
  • Oh KJ, Barbuto S, Pitter K, et al. A membrane-targeted BID BCL-2 homology 3 peptide is sufficient for high potency activation of BAX in vitro. J Biol Chem 2006;281(48):36999-7008
  • Prive GG, Melnick A. Specific peptides for the therapeutic targeting of oncogenes. Curr Opin Genet Dev 2006;16(1):71-7
  • Talmadge JE. Pharmacodynamic aspects of peptide administration biological response modifiers. Adv Drug Deliv Rev 1998;33(3):241-52
  • Lipka E, Crison J, Amidon GL. Transmembrane transport of peptide type compounds: prospects for oral delivery. J Control Rel 1996;39(2-3):121-9
  • Chandran SS, Nan A, Rosen DM, et al. A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancer. Mol Cancer Ther 2007;6(11):2928-37
  • Urry DW, Luan C-H, Parker TM, et al. Temperature of polypeptide inverse temperature transition depends on mean residue hydrophobicity. J Am Chem Soc 1991;113:4346-8
  • Meyer DE, Kong GA, Dewhirst MW, et al. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. Cancer Res 2001;61(4):1548-54
  • Allen TM. Liposomal drug formulation: rationale for development and what we can expect in the future. Drugs 1998;56:747-56
  • Kissel M, Peschke P, Subr V, et al. Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors. PDA J Pharm Sci Technol 2001;55(3):191-201
  • Bidwell GL 3rd, Raucher D. Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy. Mol Cancer Ther 2005;4(7):1076-85
  • Chow DC, Dreher MR, Trabbic-Carlson K, et al. Ultra-high expression of a thermally responsive recombinant fusion protein in E. coli. Biotechnol Prog 2006;22(3):638-46
  • Cassidy J, Duncan R, Morrison GJ, et al. Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model. Biochem Pharmacol 1989;38(6):875-9
  • Maeda H, Seymour LW, Miyamoto Y. Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug Chem 1992;3(5):351-62
  • Takakura Y, Fujita T, Hashida M, et al. Disposition characteristics of macromolecules in tumor-bearing mice. Pharm Res 1990;7(4):339-46
  • Yamaoka T, Tabata Y, Ikada Y. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J Pharm Sci 1994;83(4):601-6
  • Yowell SL, Blackwell S. Novel effects with polyethylene glycol modified pharmaceuticals. Cancer Treat Rev 2002;28(Suppl A):3-6
  • Burnham NL. Polymers for delivering peptides and proteins. Am J Hosp Pharm 1994;51(2):210-8; quiz 28-9
  • Duncan R, Coatsworth JK, Burtles S. Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1). Hum Exp Toxicol 1998;17(2):93-104
  • Seymour LW, Duncan R, Kopeckova P, et al. Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery. Cancer Treat Rev 1987;14(3-4):319-27
  • Yeung TK, Hopewell JW, Simmonds RH, et al. Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat. Cancer Chemother Pharmacol 1991;29(2):105-11
  • St'astny M, Strohalm J, Plocova D, et al. A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier. Eur J Cancer 1999;35(3):459-66
  • Ryser HJ, Shen WC. Conjugation of methotrexate to poly(L-lysine) increases drug transport and overcomes drug resistance in cultured cells. Proc Natl Acad Sci USA 1978;75(8):3867-70
  • Ohkawa K, Hatano T, Yamada K, et al. Bovine serum albumin-doxorubicin conjugate overcomes multidrug resistance in a rat hepatoma. Cancer Res 1993;53(18):4238-42
  • Minko T, Kopeckova P, Pozharov V, et al. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Control Rel 1998;54(2):223-33
  • Urry DW. Free energy transduction in polypeptides and proteins based on inverse temperature transitions. Prog Biophys Mol Biol 1992;57(1):23-57
  • Liu W, Dreher MR, Furgeson DY, et al. Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. J Control Rel 2006
  • Dreher MR, Liu W, Michelich CR, et al. Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors. Cancer Res 2007;67(9):4418-24
  • Marco A, Arcamone F. DNA complexing antibiotics: daunomycin, adriamycin and their derivatives. Arzneimittelforschung 1975;25(3):368-74
  • Ross WE, Bradley MO. DNA double-stranded breaks in mammalian cells after exposure to intercalating agents. Biochim Biophys Acta 1981;654(1):129-34
  • Ling YH, Priebe W, Perez-Soler R. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res 1993;53(8):1845-52
  • Handa K, Sato S. Generation of free radicals of quinone group-containing anti-cancer chemicals in NADPH-microsome system as evidenced by initiation of sulfite oxidation. Gann 1975;66(1):43-7
  • Goodman J, Hochstein P. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. Biochem Biophys Res Commun 1977;77(2):797-803
  • Myers CE, McGuire WP, Liss RH, et al. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 1977;197(4299):165-7
  • Triton TR, Yee G. The anticancer agent adriamycin can be actively cytotoxic without entering cells. Science 1982;217(4556):248-50
  • Olson HM, Capen CC. Chronic cardiotoxicity of doxorubicin (adriamycin) in the rat: morphologic and biochemical investigations. Toxicol Appl Pharmacol 1978;44(3):605-16
  • Olson HM, Capen CC. Subacute cardiotoxicity of adriamycin in the rat: biochemical and ultrastructural investigations. Lab Invest 1977;37(4):386-94
  • Olson RD, Boerth RC, Gerber JG, et al. Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress. Life Sci 1981;29(14):1393-401
  • Olson RD, Mushlin PS. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J 1990;4(13):3076-86
  • Denny WA. DNA-intercalating ligands as anti-cancer drugs: prospects for future design. Anticancer Drug Des 1989;4(4):241-63
  • Dano K. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta 1973;323(3):466-83
  • Long SB, Hancock PJ, Kral AM, et al. The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics. Proc Natl Acad Sci USA 2001;98(23):12948-53
  • Mutoh M, Lung FD, Long YQ, et al. A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells. Cancer Res 1999;59(14):3480-8
  • Bonfanti M, Taverna S, Salmona M, et al. p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res 1997;57(8):1442-6
  • Selivanova G, Iotsova V, Okan I, et al. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nat Med 1997;3(6):632-8
  • Wang B, Yang H, Liu YC, et al. Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry 1999;38(38):12499-504
  • Blondelle SE, Houghten RA. Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry 1992;31(50):12688-94
  • Leuschner C, Hansel W. Membrane disrupting lytic peptides for cancer treatments. Curr Pharm Des 2004;10(19):2299-310
  • Lee DG, Kim HN, Park Y, et al. Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. Biochim Biophys Acta 2002;1598(1-2):185-94
  • Massodi I, Bidwell GL 3rd, Raucher D. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. J Control Rel 2005;108(2-3):396-408
  • Liu W, Dreher MR, Chow DC, et al. Tracking the in vivo fate of recombinant polypeptides by isotopic labeling. J Control Rel 2006;114(2):184-92
  • Fujiwara K, Watanabe T. Effects of hyperthermia, radiotherapy and thermoradiotherapy on tumor microvascular permeability. Acta Pathol Jpn 1990;40(2):79-84
  • Gerlowski LE, Jain RK. Effect of hyperthermia on microvascular permeability to macromolecules in normal and tumor tissues. Int J Microcirc Clin Exp 1985;4(4):363-72
  • Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987;6(4):559-93
  • Raucher D, Chilkoti A. Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia mediated phase transition. Cancer Res 2001;In press
  • Meyer DE, Shin BC, Kong GA, et al. Drug targeting using thermally responsive polymers and local hyperthermia. J Control Rel 2001;74(1-3):213-24
  • Graslund A, Eriksson LE. Properties and applications of cell-penetrating peptides. Genet Eng (NY) 2004;26:19-31
  • Derossi D, Joliot AH, Chassaing G, et al. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994;269(14):10444-50
  • Weeks BS, Desai K, Loewenstein PM, et al. Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. J Biol Chem 1993;268(7):5279-84
  • Hawiger J. Noninvasive intracellular delivery of functional peptides and proteins. Curr Opin Chem Biol 1999;3(1):89-94
  • Saalik P, Elmquist A, Hansen M, et al. Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjug Chem 2004;15(6):1246-53
  • Silhol M, Tyagi M, Giacca M, et al. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem 2002;269(2):494-501
  • van Deurs B, Petersen OW, Olsnes S, et al. The ways of endocytosis. Int Rev Cytol 1989;117:131-77
  • Sandvig K, van Deurs B. Endocytosis without clathrin. Trends Cell Biol 1994;4(8):275-7
  • Sandvig K, van Deurs B. Endocytosis without clathrin (a minireview). Cell Biol Int Rep 1991;15(1):3-8
  • Heuser JE, Anderson RG. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol 1989;108(2):389-400
  • Thyberg J. Caveolae and cholesterol distribution in vascular smooth muscle cells of different phenotypes. J Histochem Cytochem 2002;50(2):185-95
  • Dreher MR, Raucher D, Balu N, et al. Evaluation of an elastin-like polypeptide-doxorubicin conjugate for cancer therapy. J Control Rel 2003;91(1-2):31-43
  • Minko T, Kopeckova P, Kopecek J. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Int J Cancer 2000;86(1):108-17
  • Kopecek J, Kopeckova P, Minko T, et al. HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. Eur J Pharm Biopharm 2000;50(1):61-81
  • Furgeson DY, Dreher MR, Chilkoti A. Structural optimization of a “smart” doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumors. J Control Rel 2006;110(2):362-9
  • Bidwell GL 3rd, Fokt I, Priebe W, et al. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin. Biochem Pharmacol 2007;73(5):620-31
  • Duncan R, Cable HC, Lloyd JB, et al. Degradation of side-chains of N-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinases. Biosci Rep 1982;2(12):1041-6
  • Bidwell GL, Davis AN, Fokt I, et al. A thermally targeted elastin-like polypeptide – doxorubicin conjugate overcomes drug resistance. Inv New Drugs 2007;In press
  • Pelengaris S, Khan M, Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002;2(10):764-76
  • Blackwood EM, Luscher B, Eisenman RN. Myc and Max associate in vivo. Genes Dev 1992;6(1):71-80
  • Schwartz JJ, Zhang S. Peptide-mediated cellular delivery. Curr Opin Mol Ther 2000;2(2):162-7
  • Pescarolo MP, Bagnasco L, Malacarne D, et al. A retro-inverso peptide homologous to helix 1 of c-Myc is a potent and specific inhibitor of proliferation in different cellular systems. FASEB J 2001;15(1):31-3
  • Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002;43(1):33-56
  • Soldani C, Bottone MG, Biggiogera M, et al. Nuclear localization of phosphorylated c-Myc protein in human tumor cells. Eur J Histochem 2002;46(4):377-80
  • Abrams HD, Rohrschneider LR, Eisenman RN. Nuclear location of the putative transforming protein of avian myelocytomatosis virus. Cell 1982;29(2):427-39
  • Walhout AJ, Gubbels JM, Bernards R, et al. c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene. Nucleic Acids Res 1997;25(8):1516-25
  • Shim H, Dolde C, Lewis BC, et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci USA 1997;94(13):6658-63
  • Ball KL, Lain S, Fahraeus R, et al. Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1. Curr Biol 1997;7(1):71-80
  • Mattock H, Lane DP, Warbrick E. Inhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein. Exp Cell Res 2001;265(2):234-41
  • Tunnemann G, Martin RM, Haupt S, et al. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J 2006;20(11):1775-84
  • Baker RD, Howl J, Nicholl ID. A sychnological cell penetrating peptide mimic of p21(WAF1/CIP1) is pro-apoptogenic. Peptides 2007;28(4):731-40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.